Mankind Pharma Limited (NSE:MANKIND)
India
· Delayed Price · Currency is INR 2,467.70
+5.90 (0.24%)
May 30, 2025, 3:30 PM IST
Mankind Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2024 | FY 2023 | FY 2023 | 2019 - 2022 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Mar '23 Mar 31, 2023 | 2019 - 2022 |
| Market Capitalization | 1,018,348 | 1,000,400 | 1,188,358 | 921,654 | 794,167 | - | Upgrade
|
| Market Cap Growth | 8.54% | -15.82% | 28.94% | 16.05% | - | - | Upgrade
|
| Enterprise Value | 1,083,367 | 960,198 | 1,148,156 | 902,241 | 774,753 | - | Upgrade
|
| Last Close Price | 2467.70 | 2424.75 | 2880.40 | 2300.75 | 1982.50 | - | Upgrade
|
| PE Ratio | 50.27 | 50.25 | 59.69 | 48.18 | 41.52 | - | Upgrade
|
| Forward PE | 48.57 | 45.13 | 51.08 | 43.88 | 40.15 | - | Upgrade
|
| PS Ratio | 8.34 | 8.20 | 9.74 | 8.92 | 7.74 | - | Upgrade
|
| PB Ratio | 6.99 | 6.87 | 8.16 | 9.63 | 8.29 | - | Upgrade
|
| P/TBV Ratio | - | - | - | 12.00 | 10.34 | - | Upgrade
|
| P/FCF Ratio | 52.15 | 51.24 | 60.86 | 50.17 | 43.23 | - | Upgrade
|
| P/OCF Ratio | 42.20 | 41.45 | 49.24 | 42.82 | 36.90 | - | Upgrade
|
| PEG Ratio | 3.28 | 2.64 | 3.10 | 1.91 | 1.87 | - | Upgrade
|
| EV/Sales Ratio | 8.87 | 7.87 | 9.40 | 8.73 | 7.55 | - | Upgrade
|
| EV/EBITDA Ratio | 35.75 | 31.82 | 38.04 | 35.57 | 30.58 | - | Upgrade
|
| EV/EBIT Ratio | 44.97 | 40.06 | 47.91 | 41.93 | 36.28 | - | Upgrade
|
| EV/FCF Ratio | 55.48 | 49.18 | 58.80 | 49.11 | 42.17 | - | Upgrade
|
| Debt / Equity Ratio | 0.58 | 0.58 | 0.58 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 2.82 | 2.82 | 2.82 | 0.08 | 0.08 | 0.09 | Upgrade
|
| Debt / FCF Ratio | 4.36 | 4.36 | 4.36 | 0.11 | 0.11 | 0.17 | Upgrade
|
| Asset Turnover | 0.62 | 0.62 | 0.62 | 0.95 | - | 0.93 | Upgrade
|
| Inventory Turnover | 1.91 | 1.91 | 1.91 | 2.18 | - | 1.84 | Upgrade
|
| Quick Ratio | 0.67 | 0.67 | 0.67 | 2.02 | 1.80 | 1.14 | Upgrade
|
| Current Ratio | 1.23 | 1.23 | 1.23 | 3.10 | 3.10 | 2.32 | Upgrade
|
| Return on Equity (ROE) | 16.62% | 16.62% | 16.62% | 22.58% | - | 18.79% | Upgrade
|
| Return on Assets (ROA) | 7.54% | 7.54% | 7.54% | 12.41% | - | 10.53% | Upgrade
|
| Return on Capital (ROIC) | 9.12% | 9.12% | 9.12% | 15.30% | - | 13.24% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.80% | 10.80% | 10.80% | 21.90% | 21.70% | 20.20% | Upgrade
|
| Earnings Yield | 1.96% | 1.99% | 1.68% | 2.08% | 2.41% | - | Upgrade
|
| FCF Yield | 1.92% | 1.95% | 1.64% | 1.99% | 2.31% | - | Upgrade
|
| Buyback Yield / Dilution | -0.87% | - | -0.87% | 0.01% | -0.15% | -0.00% | Upgrade
|
| Total Shareholder Return | - | - | -0.87% | 0.01% | -0.15% | -0.00% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.